What Researchers Did
Researchers investigated the effect of a single hyperbaric oxygen exposure at 2.5 atmospheres absolute (ATA) on B-type natriuretic peptide (BNP) levels in eight healthy volunteers.
What They Found
Among the eight healthy volunteers, no significant difference in BNP levels was found between baseline (T0) and immediately after hyperbaric oxygen exposure (T1), nor at 5 hours post-exposure (T2).
This preliminary study concluded that a single hyperbaric oxygen session does not significantly modify BNP plasma levels in healthy subjects.
What This Means for Canadian Patients
For Canadian patients undergoing hyperbaric oxygen therapy, this study suggests that a single session may not significantly impact B-type natriuretic peptide levels, a marker often used for cardiac function.
This information could be relevant for monitoring cardiac health in patients receiving hyperbaric oxygen, particularly those without pre-existing cardiac conditions.
Canadian Relevance
This study has no direct Canadian connection as it was conducted by researchers outside of Canada.
Study Limitations
A key limitation of this preliminary study is its small sample size of eight healthy volunteers, which may limit the generalizability of the findings.